Sinofn Health
Sinofn Health
The Seoul market represents a high-barrier, high-reward environment for Foods for Special Medical Purposes (FSMP). With South Korea’s rapidly aging demographic and a sophisticated consumer base, the demand for precision nutrition—specifically for metabolic disorders, oncology support, and sarcopenia—is skyrocketing.
Navigating the MFDS (Ministry of Food and Drug Safety) requirements requires a manufacturing partner that understands more than just production; it requires a deep integration of clinical documentation and stability validation. SINOFN acts as the bridge, combining the massive production scale and supply chain resilience of Chinese manufacturing with the rigorous quality standards expected by Seoul’s clinical institutions.
Our approach in the Seoul market focuses on "Metabolic Personalization." By leveraging our CAS (Chinese Academy of Sciences) partnership, we develop formulations that optimize bioavailability. We are currently implementing blockchain-based batch tracking, ensuring that every unit entering the Seoul distribution network is fully traceable, a critical requirement for hospital-grade FSMP supply.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group. Founded in 2012 and backed by the Chinese Academy of Sciences, we transitioned into the international market in 2025. Our Shanghai trading hub serves as the primary gateway for Seoul partners to access our Tianjin R&D capabilities.
Mrs. GuoHong Liu, Founder of SINOFN, witnessed the disparity in access to specialized clinical diets during her early medical career. Her mission was clear: to democratize access to life-sustaining FSMP formulas. Today, this mission defines our culture—profit with purpose, ensuring that our manufacturing services for global brands also contribute to the accessibility of specialized nutrition.
Medical Innovation Director
Ph.D Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead
Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems.
Formulation Director
Senior Scientist (Netherlands). EU regulatory specialist in nutraceutical delivery tech.
Our manufacturing complex is built for high-compliance environments like South Korea. With GMP certifications (ISO 22000, HACCP, FSSC 22000), our infrastructure handles everything from softgels to complex powder admixtures. We emphasize Supply Chain Resilience—by maintaining vertical integration of raw materials, we insulate our Seoul-based clients from volatility.
Inquire About Our FacilitiesA: We work alongside local regulatory consultants to ensure all labels, ingredients, and documentation align with MFDS (Ministry of Food and Drug Safety) standards, facilitating smoother customs and hospital entry.
A: Absolutely. Our pilot-scale prototyping lines allow for small-batch testing of specialized formulas, enabling you to test market reception before scaling production.
